Table 2.
Characteristics of participants by cumNon-HDL-C concentration.
| Characteristics | Total | Quintiles of cumNon-HDL-C concentration (mmol/L) | ||||
|---|---|---|---|---|---|---|
| <10.93 | 10.93–12.68 | 12.69–14.32 | 14.33–16.72 | ≥16.73 | ||
| Subjects, n% | 49,679 | 9,954 (20.0) | 9,918 (20.0) | 9,950 (20.0) | 9,920 (20.0) | 9,937 (20.0) |
| ASCVD, n% | 1,134 (2.3) | 144 (1.4) | 169 (1.7) | 207 (2.1) | 245 (2.5) | 369 (3.7) |
| Age, years | 52.44 ± 11.75 | 48.87 ± 11.76 | 50.33 ± 11.56 | 51.95 ± 11.48 | 54.23 ± 11.19 | 56.81 ± 11.04 |
| Male, n% | 37,851 (76.2) | 7,133 (71.7) | 7,626 (76.9) | 7,947 (79.9) | 7,690 (77.5) | 7,455 (75.0) |
| Physic, n% | 7,038 (14.2) | 1,216 (12.2) | 1,268 (12.8) | 1,245 (12.5) | 1,548 (15.6) | 1,761 (17.7) |
| Smoke, n% | 17,082 (34.4) | 3,362 (33.8) | 3,474 (35.0) | 3,501 (35.2) | 3,413 (34.4) | 3,332 (33.5) |
| Drink, n% | 3,054 (6.1) | 581 (5.8) | 613 (6.2) | 625 (6.3) | 631 (6.4) | 604 (6.1) |
| HTN, n% | 21,816 (43.9) | 3,314 (33.3) | 3,796 (38.3) | 4,411 (44.3) | 4,872 (49.1) | 5,423 (54.6) |
| Systolic BP, mmHg | 130.32 ± 19.12 | 125.03 ± 18.14 | 127.79 ± 18.0 | 130.37 ± 18.34 | 132.84 ± 19.08 | 135.63 ± 20.14 |
| Diastolic BP, mmHg | 84.22 ± 10.81 | 81.75 ± 10.70 | 83.39 ± 10.60 | 84.70 ± 10.39 | 85.30 ± 10.77 | 85.97 ± 11.08 |
| DM, n% | 4,997 (10.1) | 586 (5.9) | 722 (7.3) | 924 (9.3) | 1,199 (12.1) | 1,566 (15.8) |
| FBG, mmol/L | 5.63 ± 1.72 | 5.34 ± 1.91 | 5.47 ± 1.35 | 5.61 ± 1.42 | 5.79 ± 1.91 | 5.96 ± 1.83 |
| TC, mmol/L | 4.99 ± 1.20 | 4.13 ± 0.69 | 4.58 ± 0.62 | 4.90 ± 0.64 | 5.29 ± 0.74 | 6.04 ± 1.81 |
| HDL-C, mmol/L | 1.56 ± 0.50 | 1.63 ± 0.66 | 1.54 ± 0.44 | 1.53 ± 0.43 | 1.55 ± 0.44 | 1.56 ± 0.45 |
| LDL-C, mmol/L | 2.62 ± 0.93 | 2.07 ± 0.63 | 2.42 ± 1.12 | 2.59 ± 0.65 | 2.82 ± 0.76 | 3.17 ± 0.97 |
| TG, mmol/L | 1.70 ± 1.70 | 1.24 ± 1.08 | 1.46 ± 1.32 | 1.65 ± 1.70 | 1.88 ± 1.65 | 2.28 ± 2.30 |
| Non-HDL-C, mmol/L | 3.43 ± 1.20 | 2.50 ± 0.85 | 3.04 ± 0.59 | 3.37 ± 0.60 | 3.74 ± 0.68 | 4.48 ± 1.75 |
| BMI, kg/m2 | 25.08 ± 3.38 | 24.13 ± 3.38 | 24.79 ± 3.35 | 25.15 ± 3.29 | 25.58 ± 3.35 | 25.78 ± 3.28 |
| Lipid-lowing drugs, n% | 782 (1.6) | 82 (0.8) | 99 (1.0) | 126 (1.3) | 174 (1.8) | 301 (3.0) |
| Antihypertensive drugs, n% | 5,003 (10.1) | 636 (6.4) | 708 (7.1) | 868 (8.7) | 1,164 (11.7) | 1,627 (16.4) |
| Hypoglycemic drugs, n% | 1,511 (3.0) | 169 (1.7) | 210 (2.1) | 274 (2.8) | 349 (3.5) | 509 (5.1) |
ASCVD, atherosclerotic cardiovascular disease; BP, blood pressure; BMI, body mass index; DM, diabetes mellitus; FBG, fasting blood glucose; HTN, hypertension; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; non-HDL-C, non-high-density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride.